Is your hospital ready for mandatory CMS reporting on inpatient glycemic safety? → Find out by taking our CMS Glycemic Safety Readiness Assessment.
Clinical Evidence
Glucose Management Protocol Development: A Successful Collaborative Effort
Setting: VA health system with 238 beds across two academic medical centers
Objective
This multidisciplinary clinical improvement initiative compares patient outcomes before and after implementation of nurse-driven standardized intravenous insulin protocol in the ICU, supported by a dose calculator software application (EndoTool).
Setting
VA health system with 238 beds across two academic medical centers.
Results
- Average blood glucose decreased from 137 to 127 mg/dL with EndoTool.
- Average blood glucose 4 hours after insulin initiation decreased from 182 to 126 mg/dL with EndoTool.
- Average peak blood glucose decreased from 255 to 219 mg/dL with EndoTool.
Conclusions
A nurse-driven standardized intravenous insulin protocol, supported by a dose calculator software application (EndoTool), improves glucose control and helps achieve tight glucose control in the ICU.
References
Authors
Melinda Davis, RN, MSN, CCRN, CNL.
Source
Presented at American Association of Critical Care Nurses National Teaching Institute Conference. Published in Critical Care Nurse, Volume 28, Issue 2, pe31.
Year
2008
Related posts
Clinical Evidence
Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System
Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System
To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.
Clinical Evidence
Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ
Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ
To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Clinical Evidence
Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ
Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ
Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields
